| 10 | Antiviral Agents (Antivirals)IBA
12/2018
-
05/2004 |
| 7 | NucleosidesIBA
10/2019
-
08/2002 |
| 7 | VaccinesIBA
11/2015
-
02/2003 |
| 6 | AntigensIBA
01/2018
-
09/2002 |
| 5 | Immunoglobulin A (IgA)IBA
12/2019
-
02/2003 |
| 5 | Reverse Transcriptase InhibitorsIBA
07/2012
-
08/2002 |
| 4 | Proteins (Proteins, Gene)FDA Link
01/2008
-
01/2003 |
| 3 | octaarginineIBA
12/2019
-
01/2018 |
| 3 | Pharmaceutical PreparationsIBA
12/2010
-
12/2006 |
| 2 | Viral AntigensIBA
12/2019
-
01/2019 |
| 2 | Immunoglobulin G (IgG)IBA
12/2019
-
01/2019 |
| 2 | RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2015
-
05/2012 |
| 2 | ThymidineIBA
07/2012
-
12/2006 |
| 2 | poly(gamma-glutamic acid) (gamma-PGA)IBA
01/2008
-
03/2007 |
| 2 | ATP-Binding Cassette Transporters (ABC Transporters)IBA
10/2004
-
01/2003 |
| 1 | PolymersIBA
02/2022 |
| 1 | CytokinesIBA
10/2020 |
| 1 | Immunoconjugates (Immunoconjugate)IBA
08/2020 |
| 1 | dolutegravirIBA
02/2020 |
| 1 | RNA (Ribonucleic Acid)IBA
02/2020 |
| 1 | Alkaline PhosphataseIBA
02/2020 |
| 1 | glycyl-glycyl-glycyl-glycineIBA
12/2019 |
| 1 | Hyaluronic Acid (Hyaluronan)IBA
12/2019 |
| 1 | Polysaccharides (Glycans)IBA
12/2019 |
| 1 | NucleotidesIBA
10/2019 |
| 1 | Amodiaquine (Camoquin)FDA Link
12/2018 |
| 1 | SugarsIBA
04/2018 |
| 1 | Single-Chain AntibodiesIBA
04/2018 |
| 1 | poly(N-vinylacetamide)IBA
01/2018 |
| 1 | acrylic acid (acrylate)IBA
01/2018 |
| 1 | FIT-039IBA
11/2015 |
| 1 | Messenger RNA (mRNA)IBA
04/2013 |
| 1 | EndoribonucleasesIBA
04/2013 |
| 1 | Organosilicon CompoundsIBA
01/2013 |
| 1 | alovudineIBA
07/2012 |
| 1 | 2',3'- didehydro- 3'- deoxy- 4'- ethynylthymidineIBA
07/2012 |
| 1 | 4- butyl- 11- (1,1,1,3,3,3- hexafluoro- 2- hydroxypropan- 2- yl)- 7- methoxy- (1,3)dioxolo(4,5- c)phenanthridin- 5(4H)- oneIBA
12/2011 |
| 1 | Viral RNAIBA
12/2010 |
| 1 | Carbolines (Beta-Carbolines)IBA
12/2010 |
| 1 | tamibaroteneIBA
07/2009 |
| 1 | diphenylmethaneIBA
06/2009 |
| 1 | SteroidsIBA
06/2009 |
| 1 | Immunoglobulin FragmentsIBA
06/2009 |
| 1 | HLA-DR Antigens (HLA-DR)IBA
06/2009 |
| 1 | gamma-carbolineIBA
04/2008 |
| 1 | Thalidomide (Thalomid)FDA Link
04/2008 |
| 1 | Vaccine AdjuvantsIBA
03/2007 |
| 1 | Recombinant ProteinsIBA
02/2007 |
| 1 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2007 |
| 1 | doxifluridineIBA
12/2006 |
| 1 | Fluorouracil (Carac)FDA LinkGeneric
12/2006 |
| 1 | ProdrugsIBA
12/2006 |
| 1 | Thymidine PhosphorylaseIBA
12/2006 |
| 1 | G-Protein-Coupled Receptor Kinase 5IBA
09/2006 |
| 1 | Transforming Growth Factors (Transforming Growth Factor)IBA
05/2006 |
| 1 | Transforming Growth Factor beta1 (TGF beta 1)IBA
05/2006 |
| 1 | nephrinIBA
05/2006 |
| 1 | Matrix Metalloproteinases (MMPs)IBA
11/2005 |
| 1 | Chemokine CXCL12IBA
11/2005 |
| 1 | cenicrivirocIBA
11/2005 |
| 1 | TAK-220IBA
08/2005 |
| 1 | ATP Binding Cassette Transporter 1IBA
04/2005 |
| 1 | Interferon-alpha (Interferon Alfa)IBA
12/2004 |
| 1 | mizoribineIBA
12/2004 |
| 1 | N- ((2,3- dihydro- 1,4- benzodioxin- 2- yl)methyl)- 5- methoxy- 1H- indole- 3- ethanamineIBA
10/2004 |